ranolazine has been researched along with Arteriosclerosis, Coronary in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (19.05) | 29.6817 |
| 2010's | 24 (57.14) | 24.3611 |
| 2020's | 10 (23.81) | 2.80 |
| Authors | Studies |
|---|---|
| Lopez-Sendon, J; Tamargo, J | 1 |
| Dechend, R | 1 |
| Binder, CJ; Ciotu, CI; Fischer, MJM; Goederle, L; Hengstenberg, C; Hohensinner, PJ; Huber, K; Kaun, C; Krivaja, Z; Krychtiuk, KA; Lenz, M; Podesser, BK; Rauscher, S; Rehberger Likozar, A; Salzmann, M; Sebestjen, M; Speidl, WS; Wojta, J | 1 |
| Chen, T; Fang, X; Huang, J; Xu, X; Zhao, Q; Zheng, J; Zhu, H | 2 |
| Tolunay, H | 1 |
| Cruz Rodriguez, JB; Kar, S | 1 |
| Khandelwal, A; Pargaonkar, VS; Schnittger, I; Tremmel, JA | 1 |
| Al-Lamee, R; Davies, JR; Foley, M; Francis, DP; Ganesananthan, S; Gerber, R; Howard, J; Keeble, TR; Malik, IS; Nijjer, S; Nowbar, AN; O'Kane, P; Petraco, R; Rajkumar, CA; Seligman, H; Sen, S; Sharp, ASP; Shun-Shin, M; Tang, KH | 1 |
| Anderson, RD; Bairey Merz, CN; Cook-Wiens, G; Handberg, EM; Pepine, CJ; Petersen, JW; Quesada, O; Samuels, B; Shufelt, C; Suppogu, N; Wei, J | 1 |
| Athyros, VG; Doumas, M; Imprialos, KP; Stavropoulos, K | 1 |
| Borzi, M; Grilli, G; Intorcia, A; Perrone, MA; Romeo, F; Sergi, D | 1 |
| Arnold, SV; Breeding, T; Gosch, KL; Jones, PG; Patel, KK; Peri-Okonny, PA; Spertus, JA | 1 |
| Bairey Merz, CN; Berman, DS; Cook-Wiens, G; Elgendy, IY; Handberg, EM; Minissian, MB; Nelson, MD; Pepine, CJ; Rambarat, CA; Shaw, LJ; Thomson, LEJ; Wei, J | 1 |
| Bulnes, JF; Sanfuentes, B | 1 |
| Arnold, SV; Belardinelli, L; Ben-Yehuda, O; Chaitman, BR; Jones, PG; Katz, A; Kosiborod, M; Li, Y; McGuire, DK; Olmsted, A; Spertus, JA; Yue, P | 1 |
| Jacobshagen, C | 1 |
| Cice, G; Cirillo, A; D'Amore, C; del Guercio, L; Della Ratta, GL; Fimiani, L; Formisano, T; Musella, F; Pellegrino, AM; Perrone-Filardi, P; Rosano, G; Savarese, G; Trimarco, B; Vitagliano, A | 1 |
| Biscaglia, S; Valgimigli, M | 1 |
| Arnold, SV; Belardinelli, L; Jones, PG; Kosiborod, M; Li, Y; Spertus, JA; Yue, P | 1 |
| Angiolillo, DJ; Gaudio, C; Greco, C; Marazzi, G; Pelliccia, F; Rollini, F; Rosano, G; Vitale, C | 1 |
| Alexander, KP; Ben-Yehuda, O; Dressler, O; Farzaneh-Far, R; Généreux, P; Iñiguez, A; James, S; Ohman, EM; Osmukhina, A; Shechter, M; Stone, GW; Weisz, G; Zurakowski, A | 1 |
| Blum, A | 1 |
| Ambrosio, G; Grant, PJ; Tamargo, J | 1 |
| Ohman, EM | 1 |
| Chatzizisis, YS; Giannoglou, GD; Giannopoulos, AA | 1 |
| Bairey Merz, CN; Berman, DS; Cook-Wiens, G; Handberg, EM; Li, D; Mehta, PK; Nelson, MD; Pepine, CJ; Sharif, B; Shaw, JL; Shufelt, C; Thompson, RB; Thomson, LEJ; Wei, J | 1 |
| César, LA; Gowdak, LH; Mansur, AP | 1 |
| Coppola, JT; Deshmukh, SH; Hermance, EV; Infantino, MN; Mindrescu, C; Patel, SR; Pinassi, E; Staniloae, CS | 1 |
| Belardinelli, L; Blackburn, B; Heo, J; Iskandrian, AE; Venkataraman, R | 1 |
| Klocke, FJ | 1 |
| Freudenberger, R; Levin, V; Martinez, MW; Nanda, S | 1 |
| Battler, A; Dvir, D | 1 |
| Köster, R; Meinertz, T | 1 |
| Henderson, RA; Timmis, AD | 1 |
| Athanasiadis, A; Sechtem, U | 1 |
| Belardinelli, L; Chen, J; Garcia, EV; Hage, FG; Heo, J; Iskandrian, AE; Venkataraman, R | 1 |
| Belardinelli, L; Kumar, K; Nieminen, T; Verrier, RL | 1 |
| Salazar, R; Taegtmeyer, H | 1 |
| Mehta, M; Pham, DQ | 1 |
| Morrow, DA; Scirica, BM | 1 |
| Scirica, BM | 1 |
18 review(s) available for ranolazine and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Ranolazine: a better understanding of its pathophysiology and patient profile to guide treatment of chronic stable angina.
Topics: Acetanilides; Angina, Stable; Coronary Artery Disease; Humans; Piperazines; Quality of Life; Ranolazine | 2022 |
Effects of the Antianginal Drugs Ranolazine, Nicorandil, and Ivabradine on Coronary Microvascular Function in Patients With Nonobstructive Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials.
Topics: Angina Pectoris; Cardiovascular Agents; Coronary Artery Disease; Humans; Ivabradine; Myocardial Ischemia; Nicorandil; Randomized Controlled Trials as Topic; Ranolazine; Treatment Outcome | 2019 |
Management of Angina Post Percutaneous Coronary Intervention.
Topics: Angina Pectoris; Calcium Channel Blockers; Coronary Artery Disease; Echocardiography, Stress; Humans; Magnetic Resonance Imaging; Percutaneous Coronary Intervention; Ranolazine | 2020 |
Ranolazine as an additional antianginal therapy in patients with stable symptomatic coronary artery disease.
Topics: Cardiovascular Agents; Coronary Artery Disease; Databases, Factual; Humans; Randomized Controlled Trials as Topic; Ranolazine | 2018 |
[Late sodium current and calcium overload--pathogenesis and adequate treatment].
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Atrial Fibrillation; Benzazepines; Calcium; Calcium Channel Blockers; Cardiovascular Agents; Coronary Artery Disease; Electrocardiography; Endothelium, Vascular; Heart Failure, Diastolic; Humans; Hypercalcemia; Ivabradine; Myocardial Ischemia; Nitrates; Piperazines; Ranolazine; Sodium; Sodium Channels; Sodium-Calcium Exchanger | 2013 |
Effects of ranolazine in symptomatic patients with stable coronary artery disease. A systematic review and meta-analysis.
Topics: Acetanilides; Angina Pectoris; Blood Pressure; Coronary Artery Disease; Heart Rate; Humans; Piperazines; Randomized Controlled Trials as Topic; Ranolazine | 2013 |
Stable angina pectoris.
Topics: Acetanilides; Angina, Stable; Benzazepines; Coronary Artery Bypass; Coronary Artery Disease; Coronary Vasospasm; Echocardiography, Stress; Exercise Test; Humans; Ivabradine; Microvessels; Nicorandil; Nitrates; Percutaneous Coronary Intervention; Piperazines; Ranolazine; Smoking Cessation; Vasodilator Agents | 2014 |
Non-haemodynamic anti-anginal agents in the management of patients with stable coronary artery disease and diabetes: A review of the evidence.
Topics: Animals; Cardiovascular Agents; Coronary Artery Disease; Diabetes Mellitus; Humans; Ranolazine; Trimetazidine; Vasodilator Agents | 2016 |
CLINICAL PRACTICE. Chronic Stable Angina.
Topics: Adrenergic beta-Antagonists; Aged; Angina, Stable; Calcium Channel Blockers; Coronary Artery Disease; Humans; Male; Myocardial Revascularization; Nitrates; Practice Guidelines as Topic; Ranolazine | 2016 |
Pharmacological approaches of refractory angina.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Cardiovascular Agents; Coronary Artery Disease; Fibrinolytic Agents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Nicorandil; Nitrates; Ranolazine | 2016 |
The metabolic treatment of patients with coronary artery disease: effects on quality of life and effort angina.
Topics: Acetanilides; Angina Pectoris; Animals; Carnitine; Clinical Trials as Topic; Coronary Artery Disease; Dichloroacetic Acid; Humans; Piperazines; Quality of Life; Ranolazine; Ribose; Surveys and Questionnaires; Trimetazidine; Vasodilator Agents | 2009 |
Conventional and novel drug therapeutics to relief myocardial ischemia.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Cardiovascular System; Coronary Artery Disease; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ivabradine; Nicorandil; Nitrates; Piperazines; Ranolazine | 2010 |
[New agents for the therapy of angina pectoris].
Topics: Acetanilides; Angina Pectoris; Benzazepines; Coronary Artery Disease; Cyclic Nucleotide-Gated Cation Channels; Double-Blind Method; Drug Approval; Enzyme Inhibitors; Humans; Ivabradine; Nicorandil; Piperazines; Randomized Controlled Trials as Topic; Ranolazine; Vasodilator Agents | 2011 |
[Almanac 2011: Stable coronary artery disease. An editorial overview of selected research that has driven recent advances in clinical cardiology].
Topics: Acetanilides; Angioplasty, Balloon, Coronary; Anti-Arrhythmia Agents; Benzazepines; Biomarkers; Cardiology; Coronary Artery Bypass; Coronary Artery Disease; Drug-Eluting Stents; Enzyme Inhibitors; Evidence-Based Medicine; Humans; Ivabradine; Natriuretic Agents; Natriuretic Peptide, Brain; Piperazines; Randomized Controlled Trials as Topic; Ranolazine; Risk Assessment; Risk Factors; Treatment Outcome | 2012 |
Mechanisms of ranolazine's dual protection against atrial and ventricular fibrillation.
Topics: Acetanilides; Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Disease; Electrocardiography; Heart Conduction System; Heart Failure; Humans; Myocardial Ischemia; Piperazines; Ranolazine; Sodium; Sodium Channel Blockers; Treatment Outcome; Ventricular Fibrillation | 2013 |
Ranolazine: a novel agent that improves dysfunctional sodium channels.
Topics: Acetanilides; Calcium Channels; Coronary Artery Disease; Drug Administration Routes; Drug Interactions; Enzyme Inhibitors; Humans; Multicenter Studies as Topic; Piperazines; Randomized Controlled Trials as Topic; Ranolazine | 2007 |
Ranolazine in patients with angina and coronary artery disease.
Topics: Acetanilides; Angina Pectoris; Coronary Artery Disease; Enzyme Inhibitors; Humans; Piperazines; Randomized Controlled Trials as Topic; Ranolazine; Risk Factors; Treatment Outcome | 2007 |
Ranolazine in patients with coronary artery disease.
Topics: Acetanilides; Angina Pectoris; Coronary Artery Disease; Humans; Piperazines; Ranolazine | 2007 |
9 trial(s) available for ranolazine and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Achieving Optimal Medical Therapy: Insights From the ORBITA Trial.
Topics: Amlodipine; Bisoprolol; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Fractional Flow Reserve, Myocardial; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isosorbide Dinitrate; Male; Middle Aged; Nicorandil; Percutaneous Coronary Intervention; Ranolazine; Treatment Outcome; Vasodilator Agents | 2021 |
Late sodium channel blockade improves angina and myocardial perfusion in patients with severe coronary microvascular dysfunction: Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction ancillary study.
Topics: Adult; Aged; Angina Pectoris; Coronary Angiography; Coronary Artery Disease; Coronary Circulation; Cross-Over Studies; Double-Blind Method; Female; Humans; Microcirculation; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Ranolazine; Severity of Illness Index; Sodium Channel Blockers | 2019 |
Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina).
Topics: Acetanilides; Aged; Angina, Stable; Coronary Artery Disease; Diabetes Mellitus, Type 2; Double-Blind Method; Enzyme Inhibitors; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Nitroglycerin; Piperazines; Ranolazine; Sodium Channel Blockers; Treatment Outcome; Vasodilator Agents | 2013 |
Comparison of the Seattle Angina Questionnaire With Daily Angina Diary in the TERISA Clinical Trial.
Topics: Acetanilides; Angina Pectoris; Coronary Artery Disease; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Enzyme Inhibitors; Follow-Up Studies; Humans; Incidence; Medical Records; Piperazines; Prospective Studies; Ranolazine; Surveys and Questionnaires; Treatment Outcome; United States | 2014 |
Comparison of the pharmacodynamic effects of ranolazine versus amlodipine on platelet reactivity in stable patients with coronary artery disease treated with dual antiplatelet therapy : The ROMAN (RanOlazine vs. aMlodipine on platelet reactivity in stable
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amlodipine; Blood Platelets; Coronary Artery Disease; Drug Therapy, Combination; Humans; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Ranolazine | 2015 |
Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.
Topics: Aged; Angina Pectoris; Coronary Artery Disease; Coronary Stenosis; Double-Blind Method; Female; Hospitalization; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Percutaneous Coronary Intervention; Ranolazine; Sodium Channel Blockers; Stroke | 2016 |
Ranolazine improves endothelial function in patients with stable coronary artery disease.
Topics: Acetanilides; Aged; Arginine; Biomarkers; C-Reactive Protein; Cardiovascular Agents; Coronary Artery Disease; Cross-Over Studies; Double-Blind Method; Endothelium, Vascular; Female; Humans; Hyperemia; Inflammation Mediators; Male; Manometry; Middle Aged; Piperazines; Ranolazine; Time Factors; Treatment Outcome; Vasodilation | 2009 |
A study of the effects of ranolazine using automated quantitative analysis of serial myocardial perfusion images.
Topics: Acetanilides; Aged; Angina Pectoris; Automation, Laboratory; Cardiovascular Agents; Coronary Artery Disease; Coronary Circulation; Exercise Test; Exercise Tolerance; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Pilot Projects; Piperazines; Ranolazine; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2009 |
Effect of ranolazine on left ventricular dyssynchrony in patients with coronary artery disease.
Topics: Acetanilides; Aged; Coronary Artery Disease; Enzyme Inhibitors; Exercise Test; Female; Follow-Up Studies; Gated Blood-Pool Imaging; Humans; Male; Piperazines; Ranolazine; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left | 2012 |
15 other study(ies) available for ranolazine and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
[Diagnostics, therapy and the importance of quality of life in patients with chronic coronary syndrome. Results oft the general practitioner care study ALTHEA].
Topics: Angina, Stable; Coronary Artery Disease; Cross-Sectional Studies; General Practitioners; Humans; Quality of Life; Ranolazine; Syndrome | 2022 |
Pharmacologic modulation of intracellular Na
Topics: Acute Coronary Syndrome; Animals; C-Reactive Protein; Cardiovascular Agents; Coronary Artery Disease; Endothelial Cells; Humans; Inflammation; Mice; Ranolazine; Sodium; Sodium Channel Blockers | 2022 |
Does Ranolazine Reduce Pain Perception With Cerebral Effect?
Topics: Acetanilides; Coronary Artery Disease; Humans; Ivabradine; Nicorandil; Pain Perception; Randomized Controlled Trials as Topic; Ranolazine | 2020 |
Response to Letter Regarding Article, "Effects of the Antianginal Drugs Ranolazine, Nicorandil and Ivabradine on Coronary Microvascular Function in Patients with Non-obstructive Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials".
Topics: Coronary Artery Disease; Humans; Ivabradine; Nicorandil; Randomized Controlled Trials as Topic; Ranolazine | 2020 |
Effect of ranolazine on symptom and quality of life in patients with angina in the absence of obstructive coronary artery disease: A case control study.
Topics: Angina Pectoris; Case-Control Studies; Coronary Artery Disease; Humans; Quality of Life; Ranolazine; Retrospective Studies; Treatment Outcome | 2020 |
Angina relates to coronary flow in women with ischemia and no obstructive coronary artery disease.
Topics: Angina Pectoris; Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Female; Humans; Ischemia; Microcirculation; Myocardial Ischemia; Ranolazine | 2021 |
The Impact of Ranolazine Treatment on Liver Tests in Patients With Coronary Artery Disease and Nonalcoholic Fatty Liver Disease.
Topics: Coronary Artery Disease; Humans; Liver Function Tests; Non-alcoholic Fatty Liver Disease; Ranolazine | 2022 |
Ranolazine treatment in the heterogeneous symptomatic stable coronary artery disease population.
Topics: Aged; Angina Pectoris; Coronary Angiography; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Quality of Life; Ranolazine; Self Report; Sodium Channel Blockers; Treatment Outcome | 2018 |
Low Diastolic Blood Pressure Is Associated With Angina in Patients With Chronic Coronary Artery Disease.
Topics: Age Factors; Aged; Angina Pectoris; Blood Pressure; Body Mass Index; Cardiovascular Agents; Coronary Artery Disease; Cross-Sectional Studies; Diastole; Diuretics; Female; Humans; Logistic Models; Male; Nitrates; Ranolazine; Renal Insufficiency, Chronic; Sex Factors; United States | 2018 |
New oral nitric oxide-dependent medications for patients with coronary artery disease who have persistent angina pectoris.
Topics: Administration, Oral; Angina, Stable; Coronary Artery Disease; Humans; Nitric Oxide; Ranolazine; Sodium Channel Blockers; Trimetazidine; Vasodilator Agents | 2015 |
Myocardial tissue deformation is reduced in subjects with coronary microvascular dysfunction but not rescued by treatment with ranolazine.
Topics: Adult; Aged; Cardiovascular Agents; Clinical Trials as Topic; Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Diastole; Female; Humans; Magnetic Resonance Imaging, Cine; Male; Microcirculation; Microvessels; Middle Aged; Myocardium; Ranolazine; Retrospective Studies; Sodium Channel Blockers; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2017 |
Ranolazine and the myocardial demand-supply balance.
Topics: Acetanilides; Angina Pectoris; Cardiovascular Agents; Coronary Artery Disease; Coronary Circulation; Exercise Test; Humans; Myocardial Ischemia; Myocardial Perfusion Imaging; Oxygen Consumption; Piperazines; Ranolazine; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2009 |
Ranolazine--treatment of ventricular tachycardia and symptomatic ventricular premature beats in ischemic cardiomyopathy.
Topics: Acetanilides; Anti-Arrhythmia Agents; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Coronary Artery Bypass; Coronary Artery Disease; Death, Sudden, Cardiac; Defibrillators, Implantable; Dyspnea; Enzyme Inhibitors; Humans; Male; Middle Aged; Piperazines; Ranolazine; Stroke Volume; Tachycardia, Ventricular; Treatment Outcome; Ventricular Premature Complexes | 2010 |
[Update coronary artery disease: important progresses in acute and chronic therapy].
Topics: Acetanilides; Angina Pectoris; Angioplasty, Balloon, Coronary; Benzazepines; Coronary Artery Disease; Early Medical Intervention; Humans; Ivabradine; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Ranolazine; Survival Rate; Thrombolytic Therapy | 2012 |
Myocardial metabolism: a new target for the treatment of heart disease?
Topics: Acetanilides; Angina Pectoris; Coronary Artery Disease; Enzyme Inhibitors; Exercise Test; Humans; Myocardium; Piperazines; Randomized Controlled Trials as Topic; Ranolazine | 2004 |